估计稀缺资源分配的条件生存益处
Ilaria Prosepe1, Nan van Geloven1, Hans de Ferrante2,3
1Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Zuid-Holland, the Netherlands.
Statistical methods in medical research
|February 17, 2026
概括
对稀缺治疗的资源配置可以通过使用条件生存益处来优化. 我们的新动态方法准确地估计了这种益处,改进了更简单的方法,以获得更好的患者结果.
科学领域:
- 生物统计学 生物统计学
- 卫生经济学 卫生经济学
- 临床流行病学临床流行病学
背景情况:
- 缺乏治疗的可用性需要有效的资源配置策略.
- 条件生存益处 (CSB) 是治疗分配的一个关键指标.
- 从观测数据中估计CSB面临诸如时间依赖混和多个时间尺度等挑战.
研究的目的:
- 开发一种动态方法来估计所有等待稀缺治疗的患者的条件生存益处 (CSB).
- 在估计生存益处时,要考虑多种版本的治疗.
- 在资源有限的环境中提高CSB估计的准确性.
主要方法:
- 使用了截面和治疗权重的逆概率 (IPTW) 的组合.
- 为CSB开发了一个动态估计策略.
- 考虑了时间依赖的混,多个时间尺度和多个治疗版本.
- 通过模拟研究验证了该方法,并将其应用于肝移植数据.
主要成果:
- 与更简单的方法相比,提出的动态方法显著改善了对条件生存益处的估计.
- 模拟研究表明了新方法的稳定性和准确性.
- 该方法成功地应用于来自Eurotransplant的真实世界肝移植数据.
结论:
- 开发的动态方法为稀缺治疗提供了更准确的条件生存益处估计.
- 这种方法通过考虑个体患者的生存概率来提高公平的资源分配.
- 这些发现对医疗保健政策和在资源有限的环境中临床决策产生重大影响.
相关概念视频
Kaplan-Meier Approach
643
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
643
Assumptions of Survival Analysis
448
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
448
Actuarial Approach
325
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
325
Introduction To Survival Analysis
860
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
860
Comparing the Survival Analysis of Two or More Groups
621
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
621
Cancer Survival Analysis
787
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
787


